HERBOLEA Closes 5M€ Series A Round Led by EU Cannabis Fund OSKARE Capital and Bruce Linton
October 26th, 2021
NEW YORK, Oct. 26, 2021 /PRNewswire/ — Herbolea, an Italian company who develops and licenses proprietary, solventless technologies to transform botanicals into superior quality products, is happy to announce the closing of its 5m EUR Series A round, of which 2.5m EUR conditioned to milestone achievement, led by the European medical and pharmaceutical cannabis specialist fund, Óskare Capital. The funds will be used to accelerate growth, expand the team and extend access to core markets, in particular, the US.
Joining Óskare Capital in the round were a number of HNWIs who equally appreciate Herbolea’s unique value proposition. Herbolea’s technology is tailored for the extraction of active ingredients from the cannabis plant, however, Herbolea are also applying the enzymatic process in adjacent verticals, such as the extraction of actives from hops. The company is currently generating 7 figure revenues and operating extraction equipment in several important geographies, including in GMP facilities, in US, Germany, Thailand and Italy.
Óskare Capital’s President, Alexandre Ouimet-Storrs comments: “As a chemical engineer by training, I immediately understood the potential this platform technology has to revolutionize the way we extract botanicals today. Herbolea’s technology can extract valuable compounds from the fresh cannabis plant, with no need to dry, at a fraction of the costs of current technologies, provide higher quality end products and is safer to operate as their process is enzyme based and does not require high pressure or solvents.”
Representing the syndicate of HNWIs, Senior Managing Director at Houlihan Lokey, Joseph Swanson, notes, “We are delighted to partner with Oskare in supporting Herbolea at this exciting time in the Company’s history. Herbolea is uniquely positioned, with patented technology and a structural cost advantage, to disrupt multiple industry verticals built on biomass extraction”.
Herbolea Biotech is an Italian extraction technology company offering industrial solventless solutions to transform botanicals into superior quality products through proprietary, highly efficient, and environmentally friendly technologies. Visit www.herbolea.com to learn more or watch a video of our processes at https://www.youtube.com/watch?v=ZjLIds9FPkQ.
About Oskare Capital
ÓSKARE CAPITAL SAS (Paris, France) currently advises Oskare Fund I ICAV (Dublin, Ireland), the first AIFM and ESG compatible Venture Capital fund with an investment focus on innovative companies and teams in Europe working on novel therapeutics (cannabinoids and other molecules) that target the endocannabinoid system as well as the ‘picks and shovels‘ of the associated ecosystem of services and products that support this fast growing global market.
The Fund will invest in startups across the entire value chain (from Seed to Patient) but will not invest in cannabis production or recreational cannabis.
For more information, please contact: Oliver Lamb by email [email protected]
SOURCE Herbolea Biotech S.p.a.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.